Welcome to our dedicated page for Sharecare news (Ticker: SHCR), a resource for investors and traders seeking the latest updates and insights on Sharecare stock.
Sharecare Inc. reports developments across a health technology business built around digital health, virtual health tools, and population well-being programs. Company news includes product and media launches for life sciences brands, condition-specific patient and provider education, augmented reality and artificial intelligence tools, and community health initiatives such as Blue Zones Project.
Sharecare updates also cover its Health Data Solutions channel, including release-of-information services for healthcare providers, privacy and compliance leadership, equity compensation matters, governance actions, and corporate-status developments. In 2024, Sharecare completed its acquisition by Altaris, after which its common stock ceased trading and was no longer listed on Nasdaq.
Summary not available.
Sharecare, a digital health company, announced an updated schedule for its participation in the UBS Global Healthcare Conference on May 24, 2022. Jeff Arnold, chairman and CEO, will present at 12:15 p.m. ET. This change is due to a revised scheduling conflict. Investors can access the webcast and related materials on investors.sharecare.com. Sharecare aims to enhance individual health management through a data-driven platform, making healthcare accessible for all.
Sharecare (Nasdaq: SHCR), a leading digital health company, will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California. Jeff Arnold, chairman and CEO, will represent the company in a fireside chat on June 15 at 3:20 p.m. PT / 6:20 p.m. ET. A webcast and related presentation materials will be available at investors.sharecare.com. Sharecare aims to optimize individual health management and enhance well-being through its comprehensive digital health platform.
Sharecare (Nasdaq: SHCR), a digital health company, reported a strong start to 2022 with Q1 revenue of $100.7 million, up 12% from the previous year. Despite a net loss of $38.3 million, the company anticipates Q2 revenue between $101 and $103 million, and full-year revenue between $470 and $500 million. The board announced a $50 million share repurchase program to enhance shareholder value, emphasizing confidence in the company's growth strategies amidst challenges including increased operational costs and a decrease in adjusted EBITDA to $0.1 million.
Sharecare (Nasdaq: SHCR), a digital health company, announced that CEO Jeff Arnold and CFO Justin Ferrero will participate in two investor conferences. They will present at the 17th Annual Needham Technology & Media Conference on May 17, 2022, at 4:30 p.m. ET, and at the UBS Global Healthcare Conference on May 23, 2022, at 7:45 a.m. ET. Webcasts and presentation materials will be available at investors.sharecare.com.
Sharecare aims to unify health management for individuals and organizations, making healthcare more accessible.
Sharecare (Nasdaq: SHCR) has introduced Sharecare+, a comprehensive health advocacy solution aimed at simplifying health experiences for individuals and families. Launching on January 1, 2023, Sharecare+ integrates various health resources into a single platform, promoting efficiency for health plans and employers. The solution offers personalized care through clinical advocates and advanced analytics, enhancing engagement in physical, mental, and social health. Sharecare+ is expected to cover ten million lives in the U.S. and aims to reduce costs while improving care outcomes.
Sharecare (Nasdaq: SHCR) announced the formation of a clinical advisory board for its home health platform, CareLinx by Sharecare, aimed at supporting nurse-caregivers. This board comprises nursing leaders from various sectors, providing strategic advice to enhance recruitment and retention in home health, addressing the projected high turnover in the nursing workforce. The initiative is expected to strengthen workplace culture and improve care offerings by integrating clinical best practices.
Sharecare (Nasdaq: SHCR), a digital health company, will report its first quarter fiscal 2022 financial results on May 12, 2022, before the market opens. The company will hold a conference call at 8:00 a.m. EDT to review these results. Interested participants can join through a dedicated phone line or via a live audio webcast. A replay will be available for about 90 days after the call.
Sharecare (SHCR) announced strategic initiatives aimed at boosting long-term performance and provided financial guidance for Q1 and full-year 2022 results. For Q4 2021, revenue surged 34% to $118.5 million, while net income jumped to $9.5 million from a loss of $28.7 million. However, the net loss for full-year 2021 widened to $85.1 million, up from $60.5 million. The company anticipates Q1 2022 revenue of $95 to $98 million and full-year revenue between $470 to $500 million. Strategic simplification includes halting its COVID-19 vaccine assistant and transitioning its PCMH business.
Sharecare (SHCR) announced it will report its fourth quarter and full year fiscal 2021 financial results on March 31, 2022, before the market opens. A conference call to discuss the results will be held at 8:00 a.m. EDT on the same day. Participants can join via telephone or online. A replay of the call will be available for about 90 days. Sharecare is a leading digital health company focused on helping individuals manage their health through a comprehensive virtual health platform.